Cleveland Leukemia Therapeutics LLC

UEI
KD8EBA9NYNN8
CAGE
Not on record
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Entity structure
Other

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Topic 255 development of a targeted therapy for acute myeloid HHSN261201100093C National Cancer Institute (NIH) $199,833

Grant awards

Award Agency Obligated Awarded
A novel ellipticine analog as a therapeutic candidate for acute myeloid leukemia R43CA141915 National Institutes of Health $153,770
Identifying small molecule inhibitors of hdmx using cell-based screening R43CA139791 National Institutes of Health $188,748

Quick answers

Is Cleveland Leukemia Therapeutics LLC registered in SAM.gov?

Cleveland Leukemia Therapeutics LLC's SAM.gov registration expired on September 30, 2011.

What is Cleveland Leukemia Therapeutics LLC's most recent federal award?

Cleveland Leukemia Therapeutics LLC's most recent federal contract award is Topic 255 development of a targeted therapy for acute myeloid (HHSN261201100093C), from National Cancer Institute (NIH), on September 30, 2011.

On GovTribe

See Cleveland Leukemia Therapeutics LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login